An FDA advisory panel has narrowly voted to allow compounding pharmacies to manufacture unapproved peptides, including BPC-157 and KPV, with the recommendation of health secretary Robert F. Kennedy Jr.[5301585][5387733] Merck has reached voluntary licensing deals with seven companies to make generic versions of an experimental HIV prevention pill in 129 low- and middle-income countries, a move that could help increase access to the medicine globally[5387733] The FDA panel also endorsed broader use of certain peptides despite a lack of substantive evidence supporting their benefits and safety, sparking concerns about the potential risks of these compounds[5326333]